Skinuva® Brite: A Safe and Effective Alternative to Hydroquinone

Share Article

In a recent publication of the Journal of Cosmetic Science, Skinuva® Brite was compared head to head to hydroquinone 4%. The study used the patient's responses along with five independent physician evaluators to grade the before and after images. The results showed that Skinuva® Brite was tolerated well in all the patients and the pigmentation was nearly 30% better on the side of the face treated with Skinuva® Brite over hydroquinone. These results support Skinuva® Brite being a safe alternative topical product for hyperpigmentation.

Treating hyperpigmentation is a very challenging problem to plastic surgeons, dermatologists, and consumers alike, and we now have a product that has been shown to be safe and effective in treating hyperpigmentation, but also been shown to be more effective than hydroquinone.

There is a consumer demand for a safe and effective non-hydroquinone skin brightening product that can be used daily. Although hydroquinone can be an effective topical product for hyperpigmentation, its long term use has been considered controversial by many providers given its potential side effects including skin intolerance, discomfort, and redness. Skinuva® Brite was developed to fill this need and provide patients a safe alternative to hydroquinone, one that is clinically shown to work even better than hydroquinone. Skinuva® Brite has accomplished just that!

In a recent publication of the Journal of Cosmetic Science, Skinuva® Brite was compared head to head to hydroquinone 4%. The study used the patient's responses along with five independent physician evaluators to grade the before and after images. The results showed that Skinuva® Brite was tolerated well in all the patients and the pigmentation was nearly 30% better on the side of the face treated with Skinuva® Brite over hydroquinone. These results support Skinuva® Brite being a safe alternative topical product for hyperpigmentation.

“I'm extremely proud of Skinuva's continued commitment to providing safe and effective products for problematic skin conditions such as scars with Skinuva Scar and now hyperpigmentation with Skinuva Brite using science and clinical data from our studies," says Christopher Zoumalan MD, Founder and CEO of Skinuva.

He continues by saying, "Treating hyperpigmentation is a very challenging problem to plastic surgeons, dermatologists, and consumers alike, and we now have a product that has been shown to be safe and effective in treating hyperpigmentation, but also been shown to be more effective than hydroquinone. This is incredible data, and we're absolutely thrilled to provide a product that can help our patients out that suffer from hyperpigmentation.”

Skinuva is currently available to both doctors and consumers. To place an order, please visit http://www.skinuva.com.

Resources:

Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study

BRANDON D. KALASHO, ARDALAN MINOKADEH, SANDY ZHANG-NUNES, RICHARD A. ZOUMALAN, NIMA L. SHEMIRANI, ANDREA R. WALDMAN, VADIM PLETZER, and CHRISTOPHER I. ZOUMALAN, Zoumalan Plastic Surgery, Beverly Hills, CA (B.D.K., R.A.Z., C.I.Z.), Skin Care and Laser Physicians of Beverly Hills, Los Angeles, CA (A.M.), Department of Ophthalmology, Keck School of Medicine of USC, Los Angeles, CA (S.Z.-N.), Eos Rejuvenation, Beverly Hills, CA(N.L.S.), Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY (A.R.W.), KlinConsult, Wellington, New Zealand (V.P.)
Accepted for publication April 13, 2020.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Laura Daniele
RAGDOLL PR
+1 (310) 666-9838
Email >